跳至主要内容
临床试验/NCT04082507
NCT04082507Unknown不适用

Alpha-fetoprotein as a Biochemical Marker in Prediction of Placenta Acreta Increta Percreta

rasha medhat abdul-hady1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
150
试验地点
1
主要终点
Maternal serum alpha-fetoprotein

研究概览

简要总结

The aim of the study is to compare between alpha-fetoproteine as a biological marker and between ultrasound and Doppler in prediction of morbid adherent placenta.

详细描述

in pregnant women withe previous cesarean section, placenta previa and ultrasonographic finding of an abnormally adherent placenta dose maternal serum alpha-fetoprotein predict prenataly the presence of morbid adherent placenta accurately?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 39 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant women with history of scarred uterus
  • plcenta previa covering the scar of previous caesarean section as diagnosed by 2DU/S
  • Gestational age from 28wks to full term

排除标准

  • pregnant women with fetus with congenital anomalies
  • pregnant women with ovarian swelling
  • pregnant women with medical disease

结局指标

主要结局

Maternal serum alpha-fetoprotein

时间窗: From 28weeks to 37 weeks

ng/ml or MOM(Multiple of the median)

次要结局

未报告次要终点

研究者

发起方
rasha medhat abdul-hady
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

rasha medhat abdul-hady

Lecturer of obstetrics and gynecology

Ain Shams University

研究点 (1)

Loading locations...

相似试验